Abbate S L, Fujimoto W Y, Brunzell J D, Kahn S E
Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle.
Metabolism. 1993 Mar;42(3):353-7. doi: 10.1016/0026-0495(93)90086-4.
The minimal model technique permits investigation of glucose and insulin interactions during a frequently sampled intravenous glucose tolerance test (FSIGT). The model allows measurement of several important variables including insulin sensitivity (SI), glucose effectiveness at basal insulin (SG), and glucose effectiveness at zero insulin (GEZI). In addition, from the FSIGT, first-phase insulin secretion (AIRglucose) and the glucose disappearance constant (Kg) can be estimated. The estimates obtained using the minimal model technique could be of importance in understanding potential relationships between carbohydrate and lipid metabolism. In studying lipoprotein lipase (LPL) activity and mass as one of the elements of lipid metabolism, heparin administration is necessary. However, the effect of administration of this agent on factors important in carbohydrate metabolism has not been fully elucidated. Therefore, to assess the effect of heparin on insulin-glucose interactions, we performed paired studies in which subjects randomly underwent FSIGT studies 20 minutes following bolus injections of heparin or saline. None of the measured parameters was influenced by heparin administration just before the FSIGT. Since these estimates were not affected by heparin administration, these studies also permitted assessment of the coefficient of variation of replicate analysis for all values generated using the minimal model technique. The coefficients of variation of replicate analysis calculated from these two studies were 16.9% for SI, 16.6% for SG, 18.3% for GEZI, 20.6% for AIRglucose, and 14.5% for Kg. These results suggest that heparin can be administered as part of a procedure that would allow concurrent assessment of various aspects of both carbohydrate and lipid metabolism.(ABSTRACT TRUNCATED AT 250 WORDS)
最小模型技术允许在频繁采样静脉葡萄糖耐量试验(FSIGT)期间研究葡萄糖与胰岛素的相互作用。该模型能够测量几个重要变量,包括胰岛素敏感性(SI)、基础胰岛素水平下的葡萄糖效能(SG)以及零胰岛素水平下的葡萄糖效能(GEZI)。此外,通过FSIGT可以估算出第一相胰岛素分泌(AIRglucose)和葡萄糖消失常数(Kg)。使用最小模型技术获得的估算值对于理解碳水化合物和脂质代谢之间的潜在关系可能具有重要意义。在研究脂蛋白脂肪酶(LPL)活性和质量作为脂质代谢的要素之一时,给予肝素是必要的。然而,这种药物对碳水化合物代谢重要因素的影响尚未完全阐明。因此,为了评估肝素对胰岛素 - 葡萄糖相互作用的影响,我们进行了配对研究,让受试者在静脉推注肝素或生理盐水20分钟后随机接受FSIGT研究。在FSIGT之前给予肝素并没有影响任何测量参数。由于这些估算值不受肝素给药的影响,这些研究还允许评估使用最小模型技术生成的所有值的重复分析变异系数。从这两项研究计算出的重复分析变异系数分别为:SI为16.9%,SG为16.6%,GEZI为18.3%,AIRglucose为20.6%,Kg为14.5%。这些结果表明,肝素可以作为一种程序的一部分进行给药,该程序能够同时评估碳水化合物和脂质代谢的各个方面。(摘要截短至250字)